CURRENT AFFAIRS

Detailed explanation-1: -Cadila Healthcare has reduced the price of its REMDAC (Remdesivir 100 mg) injection to Rs 899 from Rs 2, 800.

Detailed explanation-2: -Seven Indian companies - Mylan, Hetero, Jubiliant Life Sciences, Cipla, Dr Reddy’s, Zydus Cadila and Sun Pharma – produce Remdesivir injections under licensing agreement with Gilead Sciences.

Detailed explanation-3: -In view of the above: 1. Remdesivir is to be used only in select moderate/ severe hospitalised Covid - 19 patients on supplemental oxygen as it is a reserve drug approved under Emergency Use Authorization only based on limited scientific evidence globally. 2.

Detailed explanation-4: -Two weeks later, on 22 October, the U.S. Food and Drug Administration (FDA) approved remdesivir for use against the pandemic coronavirus SARS-CoV-2 in the United States-the first drug to receive that status.